Objective: The burden of diabetes on individuals, healthcare systems, and society must be explored to improve and sustain diabetes care. With this aim, we estimated both past and future diabetes-related direct health expenditures in Slovenia.
Methods: Analysis of expenditures from the healthcare payer perspective during the 2019-2022 period was based on individual patient data on expenditures for seven groups of diabetes-related medical conditions from the population-level database of the Health Insurance Institute of Slovenia. Expenditure projections were prepared using the European Commission's methodology for budgetary projections.
Results: In the 2019-2022 period, average annual diabetes-related expenditures equaled €174.1 million (€1,108 per patient), with their average annual growth rate reaching 12.5%. Expenditures due to inpatient care (33%) and drugs used in diabetes (24%) had the highest shares. More than half of the expenditures were due to complications of diabetes. The diabetes-related expenditures as a share of GDP are projected to increase by 19.2% from 2019 to 2030, with slower yet continued growth up to 2050.
Conclusions: Diabetes-related expenditures in Slovenia continue to rise. By focusing on the prevention and optimal management of diabetes, its impact on the healthcare system could be reduced significantly, given the magnitude of expenditures attributed to complications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/14737167.2024.2302423 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The impact of diabetes mellitus on tendon pathology: a review.
Front Pharmacol
November 2024
Department of Orthopedics, Sports Medicine and Arthroscopy, Affiliated Fuyang People's Hospital of Anhui Medical University, Fuyang, Anhui, China.
Diabetes is one of the most common metabolic diseases worldwide, leading to complications, mortality, and significant healthcare expenditures, which impose a substantial social and financial burden globally. A diabetic environment can induce metabolic changes, negatively affecting tendon homeostasis, leading to alterations in biomechanical properties and histopathology. Numerous studies have investigated the mechanisms through which diabetes exerts pathological effects on tendons, including increased free radical production, oxidative stress, inflammatory responses, deposition of advanced glycation end products (AGEs), and microvascular changes.
View Article and Find Full Text PDFModelling the potential impact of a tax on fruit juice in South Africa: implications for the primary prevention of type 2 diabetes and health financing.
BMC Nutr
October 2024
SAMRC/Wits Centre for Health Economics and Decision Science - PRICELESS SA, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa.
Background: South Africa is experiencing a persistent growth in non-communicable diseases. Diabetes is among the top ten causes of mortality, especially among women, which is partly driven by high levels of added sugar consumption and obesity. To reduce obesity rates and the incidence of diabetes, South Africa introduced a tax on sugar sweetened beverages (also known as the Health Promotion Levy (HPL)) in 2018.
View Article and Find Full Text PDFApplication of type II diabetes incidence and mortality rates for insurance.
PLoS One
September 2024
Department of Accounting Information, Chihlee University of Technology, New Taipei City, Taiwan, Republic of China.
Article Synopsis
- - The global aging population is leading to increased medical spending on chronic diseases like heart disease and diabetes, which negatively impacts mortality improvement rates.
- - In the U.S., diabetes alone cost an estimated $327 billion in 2017, with a significant portion of the population unaware they have the disease, contributing to rising death rates, as seen in Taiwan where diabetes was the 5th leading cause of death in 2019.
- - The study applies mortality models to assess diabetes trends in Taiwan, revealing that comprehensive diabetes medication can lower mortality rates, and explores the implications for designing effective diabetes insurance products, including ethical concerns regarding diagnosis and coverage.
Enhancing pharmacist intervention targeting based on patient clustering with unsupervised machine learning.
Expert Rev Pharmacoecon Outcomes Res
September 2024
Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center College of Pharmacy, Memphis, TN, USA.
Objectives: Adherence to the American Diabetes Association (ADA) Standards of Medical Care is low. This study aimed to assist pharmacists in identifying patients for diabetes control interventions using unsupervised machine learning.
Methods: This study analyzed the 2021 Medical Expenditure Panel Survey and used a k-mode cluster analysis.
Modeling the Clinical and Economic Burden of Therapeutic Inertia in People with Type 2 Diabetes in Saudi Arabia.
Adv Ther
November 2024
College of Pharmacy, Alfaisal University, Riyadh, Saudi Arabia.
Introduction: Therapeutic inertia in type 2 diabetes, defined as a failure to intensify treatment despite poor glycemic control, can arise due to a variety of factors, despite evidence linking improved glycemic control with reductions in diabetes-related complications. The present study aimed to evaluate the health and economic burden of therapeutic inertia in people with type 2 diabetes in Saudi Arabia.
Methods: The IQVIA Core Diabetes Model (v.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!